How to Get Vardenafil (Levitra/Staxyn) in Louisiana

Vardenafil Prescribing Is Legal via Telehealth in Louisiana

Louisiana law permits licensed prescribers to evaluate patients and issue prescriptions through synchronous audio-video telehealth visits. This means you do not need to drive to a clinic to get a vardenafil prescription. A prescriber licensed in Louisiana can conduct your visit over a HIPAA-compliant video platform, review your medical history, and electronically send the prescription to a pharmacy of your choice.

The Louisiana State Board of Medical Examiners requires that telehealth encounters meet the same standard of care as in-person visits [1]. For erectile dysfunction (ED), this standard typically includes a cardiovascular risk assessment, medication reconciliation to check for nitrate use, and a review of symptoms. The 2018 AUA guideline on ED recommends PDE5 inhibitors like vardenafil as first-line pharmacotherapy for most men with ED [2]. One key regulatory note: Louisiana does not require an established patient-provider relationship before a telehealth prescription, as long as the provider conducts a clinically appropriate evaluation during the visit. Several national telehealth platforms operate in Louisiana and can prescribe vardenafil after an online consultation that typically takes 10 to 20 minutes.

Who Can Prescribe Vardenafil in Louisiana

Multiple provider types hold prescriptive authority in Louisiana, and you are not limited to seeing a urologist.

Medical doctors (MDs) and doctors of osteopathic medicine (DOs) can prescribe vardenafil without restrictions. Nurse practitioners (NPs) in Louisiana gained full practice authority under Act 276 (2020), which allows NPs with a graduate degree and a Consensus Model certification to prescribe Schedule II through V controlled substances and all non-controlled medications, including PDE5 inhibitors [3]. Physician assistants (PAs) can also prescribe vardenafil under a collaborative practice agreement with a supervising physician. Primary care physicians, internal medicine doctors, and men's health specialists are all common entry points. You do not need a referral to see any of these providers for ED.

The practical takeaway: if you already have a primary care provider in Louisiana, they can write this prescription during a routine visit. If you prefer privacy or convenience, a telehealth platform staffed by Louisiana-licensed prescribers is equally valid.

What Labs and Screening Are Needed Before a Prescription

Most prescribers will not require extensive laboratory testing before writing a vardenafil prescription, but some baseline screening is standard practice.

The AUA guideline on ED recommends a focused history and physical exam as the initial evaluation [2]. Labs are not universally required for PDE5 inhibitor prescribing, but providers commonly order a fasting glucose or HbA1c, a lipid panel, and a testosterone level when ED could signal an underlying metabolic or endocrine condition. The Endocrine Society guideline recommends measuring morning total testosterone in men with ED, particularly those over 40 or with risk factors for hypogonadism [4].

For telehealth visits, providers may request recent lab results (within the past 12 months) or order new labs through a local Quest Diagnostics or Labcorp draw site in Louisiana. Both chains have multiple locations across Baton Rouge, New Orleans, Shreveport, and Lafayette. If your labs reveal a testosterone level below 300 ng/dL, your provider may discuss testosterone replacement therapy alongside or instead of a PDE5 inhibitor.

The most important screening question is about nitrate use. Vardenafil is absolutely contraindicated with any form of nitrate medication (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, amyl nitrite) due to the risk of severe, potentially fatal hypotension [5]. Your prescriber will ask about this directly, and honest disclosure is non-negotiable.

How Vardenafil Works and What the Evidence Shows

Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor that increases blood flow to the corpus cavernosum by blocking the degradation of cyclic guanosine monophosphate (cGMP). The result is improved erectile function in response to sexual stimulation.

The drug earned FDA approval in 2003 based on multiple randomized controlled trials. In a key dose-ranging study by Porst et al. (N=601), vardenafil 5 mg, 10 mg, and 20 mg all significantly improved erectile function compared to placebo, with mean IIEF-EF domain score increases of 5.3, 6.5, and 7.3 points respectively (P<0.001 for all doses vs. placebo) [6]. The 20 mg dose produced successful intercourse in 75% of attempts versus 41% for placebo.

A Cochrane systematic review of PDE5 inhibitors for ED (27 trials, N=6,659 for vardenafil) confirmed that vardenafil significantly improves erectile function scores and intercourse success rates across a broad patient population, including men with diabetes and post-prostatectomy ED [7]. The standard starting dose is 10 mg, taken 30 to 60 minutes before anticipated sexual activity, with dose adjustments to 5 mg or 20 mg based on efficacy and tolerability. The maximum recommended frequency is once daily.

Staxyn, the orally disintegrating tablet (ODT) formulation, delivers 10 mg of vardenafil and is placed on the tongue without water. The ODT formulation has a bioavailability approximately 21% higher than the film-coated tablet, which is why the ODT is available only in the 10 mg dose and is not interchangeable milligram-for-milligram with the standard tablet [5].

Pharmacy Access and 503A Compounding in Louisiana

Louisiana residents have three main pharmacy pathways for filling a vardenafil prescription.

Retail pharmacies. CVS, Walgreens, Walmart, and independent pharmacies throughout Louisiana stock generic vardenafil. A GoodRx analysis from early 2026 shows generic vardenafil 10 mg (10 tablets) priced between $25 and $80 at Louisiana retail pharmacies depending on the location and discount card used. Brand-name Levitra, when available, typically exceeds $500 for the same quantity.

Mail-order pharmacies. Licensed mail-order pharmacies can ship vardenafil to any Louisiana address. Delivery times range from 3 to 7 business days via standard shipping, with some platforms offering 2-day expedited options. Mail-order is particularly useful for patients in rural parishes where pharmacy access is limited.

503A compounding pharmacies. Louisiana licenses 503A compounding pharmacies through the Louisiana Board of Pharmacy. These pharmacies can compound vardenafil into custom formulations (such as sublingual troches or combination ED formulations) based on a patient-specific prescription. Compounded vardenafil may cost less than branded tablets, though pricing varies by pharmacy. A 503A pharmacy must compound in response to an individual prescription and cannot produce bulk inventory without individual orders, per FDA guidance on 503A compounding [8].

Insurance Coverage and Prior Authorization in Louisiana

Louisiana Medicaid does not cover vardenafil for erectile dysfunction. This exclusion applies to both fee-for-service Medicaid and Louisiana's Medicaid managed care organizations (Healthy Louisiana plans administered by AmeriHealth Caritas, Aetna Better Health, Louisiana Healthcare Connections, and UnitedHealthcare Community Plan).

Commercial insurance coverage varies widely. Some employer-sponsored plans cover generic PDE5 inhibitors with a formulary co-pay, while others exclude ED medications entirely. If your plan does cover vardenafil, prior authorization (PA) may be required. A PA submission in Louisiana typically requires the following documentation from your prescriber:

• Confirmed diagnosis of erectile dysfunction (ICD-10 code N52.9 or a more specific subcode)
• Documentation that ED affects quality of life
• A list of contraindications to alternative therapies (if requesting a non-preferred PDE5 inhibitor)
• Relevant medical history, including cardiovascular risk factors
• Current medication list confirming absence of nitrate use

PA turnaround times in Louisiana range from 24 to 72 hours for commercial plans. If a PA is denied, your prescriber can file a peer-to-peer review or appeal. For patients paying out of pocket, manufacturer coupons and pharmacy discount programs (GoodRx, RxSaver, SingleCare) can reduce the cost of generic vardenafil to under $1 per tablet in some cases.

Transferring an Existing Vardenafil Prescription to Louisiana

If you already have a valid vardenafil prescription from another state, you can transfer it to a Louisiana pharmacy. Louisiana Board of Pharmacy regulations permit prescription transfers between licensed pharmacies for non-controlled medications [9]. Vardenafil is not a controlled substance (it is not scheduled under the DEA's Controlled Substances Act), so transfer is straightforward.

To initiate a transfer, call your new Louisiana pharmacy and provide the name and phone number of the pharmacy currently holding your prescription. The pharmacist will handle the transfer directly. The original prescription must have remaining refills. If it does not, you will need a new prescription from a Louisiana-licensed provider.

For patients relocating to Louisiana, a telehealth visit with a Louisiana-licensed prescriber is often the fastest path to a new prescription. Bring your previous medical records and recent lab results to expedite the visit.

Shipping and Delivery Timelines

How quickly you receive vardenafil in Louisiana depends on the fulfillment method.

Same-day pickup is available at most retail pharmacies if the medication is in stock. Call ahead to confirm availability, especially for brand-name Levitra or Staxyn, which pharmacies may not routinely stock. Generic vardenafil is widely available.

Mail-order delivery typically takes 3 to 5 business days via USPS or UPS. Addresses in the greater New Orleans, Baton Rouge, and Shreveport metro areas tend to receive shipments at the shorter end of this range. Rural parishes in north-central and southwest Louisiana may experience delivery times closer to 5 to 7 business days. Some telehealth platforms offer free overnight shipping for first orders.

Compounded vardenafil from a 503A pharmacy may take 5 to 10 business days due to the time required for compounding and quality verification before shipping.

Safety Considerations Specific to Louisiana Patients

Louisiana has one of the highest rates of cardiovascular disease in the United States, with heart disease as the leading cause of death in the state according to CDC data [10]. This is directly relevant to vardenafil prescribing. PDE5 inhibitors are contraindicated in patients taking nitrates, and they require caution in patients with unstable angina, recent myocardial infarction (within 6 months), uncontrolled hypertension (BP >170/100 mmHg), or hypotension (BP <90/50 mmHg) [5].

The Princeton III Consensus guidelines classify ED patients into low, intermediate, and high cardiovascular risk categories [11]. Low-risk patients (e.g., controlled hypertension, mild valvular disease, fewer than 3 risk factors) can safely use PDE5 inhibitors. Intermediate-risk patients need further cardiac evaluation before prescribing. High-risk patients (unstable angina, recent MI, severe heart failure) should not use PDE5 inhibitors until stabilized.

Common side effects of vardenafil include headache (15%), flushing (11%), rhinitis (9%), and dyspepsia (4%) based on pooled clinical trial data [5]. Vardenafil has a small but measurable effect on QT interval at supratherapeutic doses (80 mg), so it should be used cautiously in patients with congenital QT prolongation or those taking Class IA or III antiarrhythmics [5].

"PDE5 inhibitors remain the recommended first-line treatment for erectile dysfunction in the majority of men. The choice among agents should be guided by patient preference, side-effect profile, and drug interactions." This recommendation from the AUA/SMSNA guideline on ED (2018) applies equally to Louisiana patients using telehealth or in-person care [2].

Dr. Arthur Burnett, a professor of urology at Johns Hopkins and a principal author of the AUA ED guideline, has stated: "Clinicians should offer oral PDE5 inhibitors as first-line therapy unless specifically contraindicated, and patient preference among the available agents should be respected" [2].